Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

RXRX is trading near the bottom of its 52-week range and below its 200-day simple moving average. Price change The price of RXRX shares has increased $0.11 since the market last closed. This is a 3.62 ...

Balancing your portfolio aligns it with your risk tolerance and goals. Rebalance by selling or buying assets to maintain your risk level. Regular rebalancing helps avoid emotion-driven investment ...

Julia Kagan is a financial/consumer journalist and former senior editor, personal finance, of Investopedia. Toby Walters is a financial writer, investor, and lifelong learner. He has a passion for ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Medalist Rating covers product that tracks indices created or licensed by Morningstar. See Disclosure for more details. Vanguard’s straightforward asset allocation approach and robust indexing methods ...

Find out all about parenthesis as this daredevil faces crunch time! Then, put your knowledge to the test in the quiz! A parenthesis is extra information added to a sentence without changing its main ...